ARCHIVES

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says

May 7, 1999

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

Funding opportunities listed.

June 11, 2004